Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors-Reference-Cited by-同舟云学术

Jak2 Is Essential for Signaling through a Variety of Cytokine Receptors

Published:1998-05 Issue:3 Volume:93 Page:385-395
ISSN:0092-8674
Container-title:Cell
language:en
Short-container-title:Cell

Author:

Parganas Evan,Wang Demin,Stravopodis Dimitrios,Topham David J,Marine Jean-Christophe,Teglund Stephan,Vanin Elio F,Bodner Sara,Colamonici Oscar R,van Deursen Jan M,Grosveld Gerard,Ihle James N

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference58 articles.

1. Action of recombinant human interleukin 6, interleukin 1 beta and proteins;Andus;Eur. J. Immunol.,1988

2. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase;Artgetsinger;Cell,1993

3. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2;Bacon;J. Exp. Med.,1995

4. Tryptophan 650 of human granulocyte colony-stimulating factor (G-CSF) receptor, implicated in the activation of JAK2, is also required for G-CSF-mediated activation of signaling complexes of the p21ras route;Barge;Blood,1996

5. Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants;Campbell;Proc. Natl. Acad. Sci. USA,1994

Cited by 938 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. JAK activity regulates mesoderm cell fate by controlling MESP1 expression;European Journal of Cell Biology;2024-12

2. Endogenous small molecule effectors in GATA transcription factor mechanisms governing biological and pathological processes;Experimental Hematology;2024-09

3. The JAK1/JAK2 inhibitor ruxolitinib inhibits mediator release from human basophils and mast cells;Frontiers in Immunology;2024-08-12

4. Unraveling the molecular and immunological landscape: Exploring signaling pathways in osteoporosis;Biomedicine & Pharmacotherapy;2024-08

5. A double-edged sword: unusual multiple severe infections with pralsetinib: a case report and literature review;Frontiers in Medicine;2024-07-30